PUBLICATION REGISTRY

Go to research.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för varlitinib. Visa hela publikationsregistret

A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publications in the selection

14 hits

Bibliografisk träff 2024-04-29

Varlitinib and Paclitaxel for EGFR/HER2 Co-expressing Advanced Gastric Cancer: A Multicenter Phase Ib/II Study (K-MASTER-13).

Koo DH, Jung M, Kim YH, Jeung HC, Zang DY, Bae WK, Kim H, Kim HS, Lee CK, Kwon WS, Chung HC, Rha SY.

Cancer Res Treat · clinical trial, phase ii; research-article; multicenter study; clinical trial, phase i; journal article · DOI 10.4143/crt.2023.1324

Bibliografisk träff 2023-07-20

Differential Protein Expression in Response to Varlitinib Treatment in Oral Cancer Cell Line: an In Vitro Therapeutic Approach.

Tanveer F, Ilyas A, Syed B, Hashim Z, Ahmed A, Zarina S.

Appl Biochem Biotechnol · journal article · DOI 10.1007/s12010-023-04642-3

Bibliografisk träff 2022-11-21

The role of YAP1 in survival prediction, immune modulation, and drug response: A pan-cancer perspective.

Hu X, Zhang Y, Yu H, Zhao Y, Sun X, Li Q, Wang Y.

Front Immunol · research support, non-u.s. gov't; research-article; journal article · DOI 10.3389/fimmu.2022.1012173

Bibliografisk träff 2022-10-20

Inhibiting EGFR/HER-2 ameliorates neuroinflammatory responses and the early stage of tau pathology through DYRK1A.

Kim J, Kim SJ, Jeong HR, Park JH, Moon M, Hoe HS.

Front Immunol · research support, non-u.s. gov't; research-article; journal article · DOI 10.3389/fimmu.2022.903309

Bibliografisk träff 2022-09-13

Differences in sensitivity to new therapies between primary and metastatic breast cancer: A need to stratify the tumor response?

Beaumont H, Faye N, Iannessi A, Chamorey E, Klifa C, Hsieh CY.

Cancer Med · research-article; journal article · DOI 10.1002/cam4.5236

Bibliografisk träff 2022-02-23

Phase Ib Dose-Finding Study of Varlitinib Combined with Weekly Paclitaxel With or Without Carboplatin ± Trastuzumab in Advanced Solid Tumors.

Lee MX, Wong ALA, Ow S, Sundar R, Tan DSP, Soo RA, Chee CE, Lim JSJ, Yong WP, Lim SE, Goh BC, Wang L, Lee SC.

Target Oncol · research support, non-u.s. gov't; research-article; clinical trial, phase i; journal article · DOI 10.1007/s11523-022-00867-0

Bibliografisk träff 2021-12-15

Varlitinib plus capecitabine in second-line advanced biliary tract cancer: a randomized, phase II study (TreeTopp).

Javle MM, Oh DY, Ikeda M, Yong WP, Hsu K, Lindmark B, McIntyre N, Firth C.

ESMO Open · clinical trial, phase ii; research support, non-u.s. gov't; research-article; randomized controlled trial; journal article · DOI 10.1016/j.esmoop.2021.100314

Bibliografisk träff 2021-06-22

Upregulation of the ErbB family by EZH2 in hepatocellular carcinoma confers resistance to FGFR inhibitor.

Prawira A, Le TBU, Ho RZW, Huynh H.

J Cancer Res Clin Oncol · research-article; journal article · DOI 10.1007/s00432-021-03703-6

Bibliografisk träff 2021-06-03

Evaluation of anti-EGFR potential of quinazoline derivatives using molecular docking: An in silico approach.

Tanveer F, Anwar MF, Siraj B, Zarina S.

Biotechnol Appl Biochem · journal article · DOI 10.1002/bab.2199

Bibliografisk träff 2020-06-11

In vitro and in vivo Anti-Tumor Effects of Pan-HER Inhibitor Varlitinib on Cholangiocarcinoma Cell Lines.

Dokduang H, Jamnongkarn W, Promraksa B, Suksawat M, Padthaisong S, Thanee M, Phetcharaburanin J, Namwat N, Sangkhamanon S, Titapun A, Khuntikeo N, Klanrit P, Loilome W.

Drug Des Devel Ther · research-article; journal article · DOI 10.2147/dddt.s250061

Bibliografisk träff 2019-10-24

Doxorubicin and Varlitinib Delivery by Functionalized Gold Nanoparticles Against Human Pancreatic Adenocarcinoma.

Coelho SC, Reis DP, Pereira MC, Coelho MAN.

Pharmaceutics · research-article; journal article · DOI 10.3390/pharmaceutics11110551

Bibliografisk träff 2019-01-17

Varlitinib Downregulates HER/ERK Signaling and Induces Apoptosis in Triple Negative Breast Cancer Cells.

Liu CY, Chu PY, Huang CT, Chen JL, Yang HP, Wang WL, Lau KY, Lee CH, Lan TY, Huang TT, Lin PH, Dai MS, Tseng LM.

Cancers (Basel) · research-article; journal article · DOI 10.3390/cancers11010105

Bibliografisk träff 2018-07-12

Gold Nanoparticles for Targeting Varlitinib to Human Pancreatic Cancer Cells.

Coelho SC, Reis DP, Pereira MC, Coelho MAN.

Pharmaceutics · research-article; journal article · DOI 10.3390/pharmaceutics10030091

Bibliografisk träff 2014-08-01

ARRY-334543 reverses multidrug resistance by antagonizing the activity of ATP-binding cassette subfamily G member 2.

Wang DS, Patel A, Sim HM, Zhang YK, Wang YJ, Kathawala RJ, Zhang H, Talele TT, Ambudkar SV, Xu RH, Chen ZS.

J Cell Biochem · research support, n.i.h., intramural; research support, non-u.s. gov't; research-article; journal article; research support, n.i.h., extramural · DOI 10.1002/jcb.24787